Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$19.1M
Filings
312
Firms Hired
5
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
2025 · second_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: H. Con. Res. 14
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: AVENUE SOLUTIONS
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1968
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to street medicine
Client expense: — · Firm income: $50,000
Matched citations: S. 891
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Client expense: — · Firm income: $40,000
Matched citations: H.R. 10545
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Client expense: — · Firm income: $40,000
Matched citations: S. 3950
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders
Client expense: — · Firm income: $40,000
Matched citations: S. 3950
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization
Client expense: — · Firm income: $40,000
Matched citations: S. 3950
Further Consolidated Appropriations Act, 2024
2024 · first_quarter · Firm: AVENUE SOLUTIONS
Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2882
Consolidated Appropriations Act, 2024
2024 · first_quarter · Firm: AVENUE SOLUTIONS
Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Client expense: — · Firm income: $40,000
Matched citations: H.R. 4366
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Senator Cassidy draft legislation on dual eligible beneficiaries; Issues related to Medicare Advantage marketing practices; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)
Client expense: — · Firm income: $40,000
Matched citations: S. 3950
Relating to a national emergency declared by the President on March 13, 2020.
2023 · first_quarter · Firm: AVENUE SOLUTIONS
H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic
Client expense: — · Firm income: $40,000
Matched citations: H.J.Res.7
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; SES (socio-economic status) issues (including Homelessness) related to special needs plan (SNP) payment rates and quality measures; CMMI discussions re: homelessness and healthcare; Health equity issues; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Draft legislation that seeks to reduce health equity gaps in the Medicare Advantage program; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; CMS RFI on Medicare Advantage; Cassidy/Scott RFI on dual eligible beneficiaries; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2166
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Senate Finance Committee bipartisan Discussion Draft: The Mental Health Parity Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to the Public Health Emergency; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2617
Improving Seniors’ Timely Access to Care Act of 2021
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; SES (socio-economic status) issues (including Homelessness) related to special needs plan (SNP) payment rates and quality measures; CMMI discussions re: homelessness and healthcare; Health equity issues; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Draft legislation that seeks to reduce health equity gaps in the Medicare Advantage program; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; CMS RFI on Medicare Advantage; Cassidy/Scott RFI on dual eligible beneficiaries; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3173
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Senate Finance Committee bipartisan Discussion Draft: The Mental Health Parity Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to the Public Health Emergency; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6833
Restoring Hope for Mental Health and Well-Being Act of 2022
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Senate Finance Committee bipartisan Discussion Draft: The Mental Health Parity Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to the Public Health Emergency; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $40,000
Matched citations: H.R. 7666
Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; SES (socio-economic status) issues (including Homelessness) related to special needs plan (SNP) payment rates and quality measures; CMMI discussions re: homelessness and healthcare; Health equity issues; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Draft legislation that seeks to reduce health equity gaps in the Medicare Advantage program; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; CMS RFI on Medicare Advantage; Cassidy/Scott RFI on dual eligible beneficiaries; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Client expense: — · Firm income: $40,000
Matched citations: S. 150
Improving Seniors’ Timely Access to Care Act of 2021
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; SES (socio-economic status) issues (including Homelessness) related to special needs plan (SNP) payment rates and quality measures; CMMI discussions re: homelessness and healthcare; Health equity issues; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Draft legislation that seeks to reduce health equity gaps in the Medicare Advantage program; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; CMS RFI on Medicare Advantage; Cassidy/Scott RFI on dual eligible beneficiaries; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Client expense: — · Firm income: $40,000
Matched citations: S. 3018
Source: Senate LDA